// App-Quantinova.ai

: Sea-BCMA Mono- and Combination Therapy in Patients with Relapsed/Refractory Multiple Myeloma: Updated Results of a Phase 1 Study (SGNBCMA-001)

Researchers

Presenter

  • James E. Hoffman

Principal Investigators

  • Brea Lipe

  • Jason Melear

  • Michaela Liedtke

  • Mark A. Schroeder

  • Ruben Niesvizky

  • Christopher Strouse

  • Christopher A. Yasenchak

  • Damian J. Green

  • Jeremy Sauer

  • Yinghui Wang

  • Phoenix Ho

  • Al-Ola Abdallah

Medical Centers

  • Willamette Valley Cancer Institute and Research Center, Eugene, OR

  • Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL

  • Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO

  • Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA

  • STANFORD UNIVERSITY MEDICAL CENTER, Stanford, CA

  • Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY

  • Texas Oncology, Austin, TX

  • Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA

  • Weill Cornell Medicine, New York, NY

  • UNIVERSITY OF KANSAS MEDICAL CENTER, KANSAS CITY, KS

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved